GlassScriptPhysician profile
Jennifer L Mitchell
NPI 1811538598
$5,025.85
in general payments reported to CMS, 2019-2025
37 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,641 · 2022: $1,667 · 2023: $807 · 2024: $616 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,717.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $746.60 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $578.47 | 2021-2025 | |
| Lilly USA, LLC | $468.09 | 2021-2024 | Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $336.99 | 2021-2024 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $307.94 | 2021-2023 | Trelegy Ellipta, Shingrix, Bexsero |
| Janssen Pharmaceuticals, INC | $249.57 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $229.27 | 2021-2024 | Jardiance, Synjardy |
| Abbott Laboratories | $223.52 | 2022-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Pfizer INC. | $187.84 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $149.44 | 2022 | |
| Acadia Pharmaceuticals INC | $136.72 | 2025 | Nuplazid |
| Amgen INC. | $129.95 | 2021-2024 | Repatha, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $120.79 | 2022-2024 | Xifaxan |
| Dexcom, INC. | $111.98 | 2023-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $100.64 | 2021-2024 | Gardasil 9, Capvaxive, Gardasil |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $87.86 | 2022-2025 | Rexulti |
| Sanofi-Aventis U.S. LLC | $85.40 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $84.24 | 2021-2022 | |
| Myriad Women'S Health, INC. | $75.60 | 2023 | Myrisk |
| Astellas Pharma US INC | $72.33 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $59.26 | 2022 | |
| Sanofi Pasteur INC. | $54.60 | 2021-2022 | |
| Cmp Pharma, INC. | $49.59 | 2021-2022 | |
| Genentech USA, INC. | $42.81 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $42.57 | 2021 | |
| Biogen, INC. | $42.35 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $40.82 | 2022-2024 | Gvoke Hypopen |
| Philips North America LLC | $38.45 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $36.89 | 2021 | |
| Kyowa Kirin, INC. | $27.64 | 2023 | Crysvita |
| Bausch Health US, LLC | $18.23 | 2021 | |
| Inspire Medical Systems, INC. | $17.60 | 2024 | Inspire |
| Organon LLC | $16.55 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.21 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $14.19 | 2021 | |
| Avanir Pharmaceuticals, INC. | $13.44 | 2021 | |
| Esperion Therapeutics, INC. | $11.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.